Both in Biotechnology
Cabaletta Bio vs Inhibikase Therapeutics
Over the past year CABA returned −47.4% and IKT returned −1.6%; their daily moves had a correlation of 0.36.
CABA −47.4% IKT −1.6%Growth of $1, one year, split-adjusted
| Metric | CABA | IKT |
|---|---|---|
| Price | $1.42 | $1.57 |
| Market cap | $240.8M | $218.4M |
| Today | 0.00% | +5.74% |
| 1 month | −29.7% | −21.0% |
| 6 months | −61.9% | −22.1% |
| Year to date | −35.2% | −23.7% |
| 1 year | −52.8% | −2.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $205.1M | $159.0M |
| Dividend yield | — | — |
| Volatility (60d) | 78.7% | 52.6% |
| Short % of float | 27.4% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).